Autobio Diagnostics Co., Ltd.
603658
Classifica tra le azioni
#4904
Autobio Diagnostics Co., Ltd. specializes in the full lifecycle of clinical... Autobio Diagnostics Co., Ltd. specializes in the full lifecycle of clinical diagnostic products, from their initial research and development to manufacturing and market distribution. Their diverse offerings encompass a range of reagents for immunoassay, biochemistry, microbiology, and in-vitro diagnostics (IVD). Additionally, they provide advanced automated and semi-automated instrumentation, alongside comprehensive medical laboratory solutions. Notable immunoassay products include the AutoLumo A2000 Plus automatic chemiluminescence immunoassay analyzer, automated microplate chemiluminescent enzyme immunoassays, LUmo luminometers, PHOmo microplate readers, and iWO microplate washers. Within their microbiology division, they offer automated blood culture systems, blood culture bottles, AUTOMIC strips, and mycoplasma IES. Founded in 1998, the company originally operated as Lifeclone Diagnostics Co., Ltd. before adopting its current name, Autobio Diagnostics Co., Ltd., in 2003. Headquartered in Zhengzhou, China, it functions as a subsidiary of Zhengzhou Auto Industrial Co., Ltd.
Prezzo delle azioni
$5.15
Ultima sincronizzazione: 2026-10-22
Capitalizzazione di mercato
$2.94B
Variazione (1 giorno)
0.97%
Variazione (1 anno)
-5.80%
Paese
CN
Scambia Autobio Diagnostics Co., Ltd. (603658)
Categoria
Healthcare
Rapporto P/B per Autobio Diagnostics Co., Ltd. (603658)
Rapporto P/B al October 2026 TTM: 2.27
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Autobio Diagnostics Co., Ltd., il rapporto P/B attuale (TTM) è 2.27. Alla fine del 2024, era pari a 2.92.
Storico del rapporto P/B per Autobio Diagnostics Co., Ltd. da 2011 a 2026
Rapporto P/B alla fine di ogni anno
| Anno | Rapporto P/B | Cambia |
|---|---|---|
| 2026 (TTM) | 2.27 | -0.17% |
| 2025 | 2.27 | -22.45% |
| 2024 | 2.92 | -23.98% |
| 2023 | 3.84 | -17.13% |
| 2022 | 4.64 | 4.57% |
| 2021 | 4.44 | -53.90% |
| 2020 | 9.62 | -39.22% |
| 2019 | 15.83 | 57.82% |
| 2018 | 10.03 | -22.97% |
| 2017 | 13.02 | -2.75% |
| 2016 | 13.39 | 21.99% |
| 2015 | 10.98 | -30.81% |
| 2014 | 15.87 | -31.58% |
| 2013 | 23.19 | -32.83% |
| 2012 | 34.52 | -42.77% |
| 2011 | 60.32 | 0.00% |
Rapporto P/B per aziende simili o concorrenti
| Azienda | Rapporto P/B | Differenza del rapporto P/B | Il paese |
|---|---|---|---|
| 4.5801 | 102.11% |
US
|
|
| 3.0725 | 35.59% |
US
|
|
| 31.4903 | 1,289.63% |
US
|
|
| 4.9326 | 117.67% |
CN
|
|
| 6.8081 | 200.43% |
US
|
